Melittin enhances radiosensitivity of hypoxic head and neck squamous cell carcinoma by suppressing HIF-1α

Tumor Biology

Volumn 35, Issue 10, 2014, Pages 10443-10448

  Yang, Xi ^a   Zhu, Hongcheng ^a   Ge, Yangyang ^b   Liu, Jia ^a   Cai, Jing ^b   Qin, Qin ^a   Zhan, Liangliang ^a   Zhang, Chi ^a   Xu, Liping ^a   Liu, Zheming ^a   Yang, Yan ^a   Yang, Yuehua ^a   Ma, Jianxin ^c   Cheng, Hongyan ^a   Sun, Xinchen ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

^c BENGBU MEDICAL COLLEGE   (China)

Author keywords

Head and neck squamous cell carcinoma; HIF 1 ; Hypoxia; Melittin; Radiosensitivity

Indexed keywords

HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MELITTIN; RADIOSENSITIZING AGENT;

ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL HYPOXIA; DRUG EFFECTS; DRUG SCREENING; HEAD AND NECK TUMOR; HUMAN; MALE; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; HEAD AND NECK NEOPLASMS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MELITTEN; MICE; MICE, INBRED BALB C; RADIATION-SENSITIZING AGENTS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84922393506     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2218-0     Document Type: Article

References (22)

1. Bauer VL, Hieber L, Schaeffner Q, Weber J, Braselmann H, Huber R, et al. Establishment and molecular cytogenetic characterization of a cell culture model of head and neck squamous cell carcinoma (HNSCC). Genes. 2010;1:388–412.
2. Bittner MI, Grosu AL. Hypoxia in head and neck tumors: characteristics and development during therapy. Frontiers Oncology. 2013;3:223.
3. Semenza GL. Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu Rev Pathol. 2014;9:47–71.
4. Yang X, Zhang C, Zhu HC, Qin Q, Zhao LJ, Liu J, et al. HIF-1alpha P582S and A588T polymorphisms and digestive system cancer risk-a meta-analysis. Tumour Biol: J Int Soc Oncodevelopmental Biol Med. 2014;35:2825–30.
5. Yang X, Zhu HC, Zhang C, Qin Q, Liu J, Xu LP, et al. HIF-1alpha 1772 C/T and 1790 G/A polymorphisms are significantly associated with higher cancer risk: an updated meta-analysis from 34 case-control studies. PLoS One. 2013;8:e80396.
6. Sadri N, Zhang PJ. Hypoxia-inducible factors: mediators of cancer progression; prognostic and therapeutic targets in soft tissue sarcomas. Cancers. 2013;5:320–33.
7. Ge X, Zhen F, Yang B, Yang X, Cai J, Zhang C, et al. Ginsenoside Rg3 enhances radiosensitization of hypoxic oesophageal cancer cell lines through vascular endothelial growth factor and hypoxia inducible factor 1alpha. J Int Med Res. 2014;42(3):628–40.
8. Yang X, Yang B, Cai J, Zhang C, Zhang Q, Xu L, et al. Berberine enhances radiosensitivity of esophageal squamous cancer by targeting HIF-1alpha in vitro and in vivo. Cancer Biol Ther. 2013;14:1068–73.
9. Zhang C, Yang X, Zhang Q, Yang B, Xu L, Qin Q, et al. Berberine radiosensitizes human nasopharyngeal carcinoma by suppressing hypoxia-inducible factor-1alpha expression. Acta Otolaryngol. 2014;134:185–92.
10. Raghuraman H, Chattopadhyay A. Melittin: a membrane-active peptide with diverse functions. Biosci Rep. 2007;27:189–223.
11. Gajski G, Garaj-Vrhovac V. Melittin: a lytic peptide with anticancer properties. Environ Toxicol Pharmacol. 2013;36:697–705.
12. Shin JM, Jeong YJ, Cho HJ, Park KK, Chung IK, Lee IK, et al. Melittin suppresses HIF-1alpha/VEGF expression through inhibition of ERK and mTOR/p70S6K pathway in human cervical carcinoma cells. PLoS One. 2013;8:e69380.
13. Wachters JE, Schrijvers ML, Slagter-Menkema L, Mastik M, de Bock GH, Langendijk JA, et al. Prognostic significance of HIF-1a, CA-IX, and OPN in T1-T2 laryngeal carcinoma treated with radiotherapy. Laryngoscope. 2013;123:2154–60.
14. Wan XB, Fan XJ, Huang PY, Dong D, Zhang Y, Chen MY, et al. Aurora-A activation, correlated with hypoxia-inducible factor-1alpha, promotes radiochemoresistance and predicts poor outcome for nasopharyngeal carcinoma. Cancer Sci. 2012;103:1586–94.
15. Hsu HW, Wall NR, Hsueh CT, Kim S, Ferris RL, Chen CS, et al. Combination antiangiogenic therapy and radiation in head and neck cancers. Oral Oncol. 2014;50:19–26.
16. Huang PY, Sun ZY, Xie CM, Chen QY, Wen YF, Li J, et al. Prognostic significance of the various classifications for parapharyngeal space involvement in nasopharyngeal carcinoma. Acta Otolaryngol. 2012;132:1197–207.
17. Xueguan L, Xiaoshen W, Yongsheng Z, Chaosu H, Chunying S, Yan F. Hypoxia inducible factor-1 alpha and vascular endothelial growth factor expression are associated with a poor prognosis in patients with nasopharyngeal carcinoma receiving radiotherapy with carbogen and nicotinamide. Clin Oncol. 2008;20:606–12.
18. Hu H, Chen D, Li Y, Zhang X. Effect of polypeptides in bee venom on growth inhibition and apoptosis induction of the human hepatoma cell line SMMC-7721 in-vitro and Balb/c nude mice in-vivo. J Pharm Pharmacol. 2006;58:83–9.
19. Yang ZL, Ke YQ, Xu RX, Peng P. [Melittin inhibits proliferation and induces apoptosis of malignant human glioma cells]. Nan fang yi ke da xue xue bao J South Med Univ. 2007;27:1775–7.
20. Li B, Gu W, Zhang C, Huang XQ, Han KQ, Ling CQ. Growth arrest and apoptosis of the human hepatocellular carcinoma cell line BEL-7402 induced by melittin. Onkologie. 2006;29:367–71.
21. Park JH, Jeong YJ, Park KK, Cho HJ, Chung IK, Min KS, et al. Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF-kappaB and AP-1-dependent MMP-9 expression. Molecules and Cells. 2010;29:209–15.
22. Jo M, Park MH, Kollipara PS, An BJ, Song HS, Han SB, et al. Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway. Toxicol Appl Pharmacol. 2012;258:72–81.